// App-Quantinova.ai

Su1203 : Diverticular Disease-Associated Segmental Colitis: a 14 Year Follow up

Researchers

Presenter

  • Flavio Habal

Principal Investigators

  • N/A

Medical Centers

  • University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • N/A

Drug/Treatment

  • Mesalamine

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved